{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:49:10Z","timestamp":1764402550896},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,15]]},"DOI":"10.1093\/aje\/kws317","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T21:52:04Z","timestamp":1357336324000},"page":"131-141","source":"Crossref","is-referenced-by-count":34,"title":["Adapting Group Sequential Methods to Observational Postlicensure Vaccine Safety Surveillance: Results of a Pentavalent Combination DTaP-IPV-Hib Vaccine Safety Study"],"prefix":"10.1093","volume":"177","author":[{"given":"Jennifer C.","family":"Nelson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onchee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara P.","family":"Dominguez-Islas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon K.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Katherine","family":"Yih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew F.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen R.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,1,4]]},"reference":[{"key":"key\n\t\t\t\t20170522100643_KWS317C1","volume-title":"The Future of Drug Safety: Promoting and Protecting the Health of the Public","author":"Baciu","year":"2007"},{"key":"key\n\t\t\t\t20170522100643_KWS317C2","volume-title":"Food and Drug Administration Amendments Act of 2007","author":"Congress of the United States","year":"2008"},{"issue":"2","key":"key\n\t\t\t\t20170522100643_KWS317C3","first-page":"186","article-title":"The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA","volume":"78","author":"Chen","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170522100643_KWS317C4","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"issue":"10 suppl 2","key":"key\n\t\t\t\t20170522100643_KWS317C5","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45","author":"Lieu","year":"2007","journal-title":"Med Care"},{"issue":"1","key":"key\n\t\t\t\t20170522100643_KWS317C6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"issue":"32","key":"key\n\t\t\t\t20170522100643_KWS317C7","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/j.vaccine.2009.05.036","article-title":"An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink","volume":"27","author":"Yih","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"key\n\t\t\t\t20170522100643_KWS317C8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e3181af8605","article-title":"Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine","volume":"29","author":"Belongia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"46","key":"key\n\t\t\t\t20170522100643_KWS317C9","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"key\n\t\t\t\t20170522100643_KWS317C10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety using prospective weekly surveillance in the Vaccine Safety Datalink Project","volume":"41","author":"Lee","year":"2011","journal-title":"Am J Prev Med"},{"issue":"34","key":"key\n\t\t\t\t20170522100643_KWS317C11","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1016\/j.vaccine.2009.05.056","article-title":"Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting","volume":"27","author":"Jacobsen","year":"2009","journal-title":"Vaccine"},{"issue":"RR03","key":"key\n\t\t\t\t20170522100643_KWS317C12","first-page":"1","article-title":"Use of combination measles, mumps, rubella, and varicella vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"key\n\t\t\t\t20170522100643_KWS317C13","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJMp1014427","article-title":"Developing the Sentinel System\u2014a national resource for evidence development","volume":"364","author":"Behrman","year":"2011","journal-title":"N Engl J Med"},{"issue":"1-2","key":"key\n\t\t\t\t20170522100643_KWS317C14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/biomet\/41.1-2.100","article-title":"Continuous inspection schemes","volume":"41","author":"Page","year":"1954","journal-title":"Biometrika"},{"issue":"2","key":"key\n\t\t\t\t20170522100643_KWS317C15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1214\/aoms\/1177731118","article-title":"Sequential tests of statistical hypotheses","volume":"16","author":"Wald","year":"1945","journal-title":"Ann Math Stat"},{"issue":"1","key":"key\n\t\t\t\t20170522100643_KWS317C16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/07474946.2011.539924","article-title":"A maximized sequential probability ratio test for drug and vaccine safety surveillance","volume":"30","author":"Kulldorff","year":"2011","journal-title":"Seq Anal"},{"issue":"26","key":"key\n\t\t\t\t20170522100643_KWS317C17","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/sim.4036","article-title":"Sequential generalized likelihood ratio tests for vaccine safety evaluation","volume":"29","author":"Shih","year":"2010","journal-title":"Stat Med"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170522100643_KWS317C18","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1542\/peds.2010-1722I","article-title":"Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project","volume":"127","author":"Yih","year":"2011","journal-title":"Pediatrics"},{"issue":"28","key":"key\n\t\t\t\t20170522100643_KWS317C19","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1002\/sim.2901","article-title":"Frequentist evaluation of group sequential clinical trial designs","volume":"26","author":"Emerson","year":"2007","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170522100643_KWS317C20","volume-title":"Pentacel Clinical Safety Review","author":"Office of Vaccine Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration","year":"2008"},{"issue":"39","key":"key\n\t\t\t\t20170522100643_KWS317C21","first-page":"1079","article-title":"Licensure of a diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, and Haemophilus b conjugate vaccine and guidance for use in infants and children","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"key\n\t\t\t\t20170522100643_KWS317C22","first-page":"1","article-title":"Recommended immunization schedules for persons aged 0\u201318 years\u2014United States, 2012","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"key\n\t\t\t\t20170522100643_KWS317C23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0b013e31805d7f17","article-title":"Use of combination vaccines is associated with improved coverage rates","volume":"26","author":"Marshall","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"key\n\t\t\t\t20170522100643_KWS317C24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00006454-200203000-00018","article-title":"Combination vaccines","volume":"21","author":"Rennels","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"key\n\t\t\t\t20170522100643_KWS317C25","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1542\/peds.2006-0114","article-title":"Use of a new combined vaccine in pediatric practices","volume":"118","author":"Freed","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"key\n\t\t\t\t20170522100643_KWS317C26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1542\/peds.2007-3317","article-title":"Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial","volume":"123","author":"Guerra","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"key\n\t\t\t\t20170522100643_KWS317C27","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0264-410X(97)00241-7","article-title":"Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age","volume":"16","author":"Mills","year":"1998","journal-title":"Vaccine"},{"issue":"5","key":"key\n\t\t\t\t20170522100643_KWS317C28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/hv.1.5.2079","article-title":"Safety and immunogenicity of a pentavalent combination vaccine (diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type B conjugate) when administered as a fourth dose at 15 to 18 months of age","volume":"1","author":"Scheifele","year":"2005","journal-title":"Hum Vaccine"},{"issue":"4","key":"key\n\t\t\t\t20170522100643_KWS317C29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1155\/2007\/289842","article-title":"Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age","volume":"18","author":"Gold","year":"2007","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"11","key":"key\n\t\t\t\t20170522100643_KWS317C30","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2010.06.037","article-title":"Immunogenicity and safety of a combined diphtheria, tetanus, 5-component acellular pertussis, inactivated poliomyelitis, Haemophilus type b conjugate vaccine when administered concurrently with a pneumococcal conjugate vaccine: a randomized, open-label, phase 3 study","volume":"29","author":"Bernstein","year":"2011","journal-title":"Vaccine"},{"issue":"46","key":"key\n\t\t\t\t20170522100643_KWS317C31","first-page":"1252","article-title":"Continued shortage of Haemophilus influenzae type b (Hib) conjugate vaccines and potential implications for Hib surveillance\u2014United States, 2008","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"key\n\t\t\t\t20170522100643_KWS317C32","first-page":"58","article-title":"Invasive Haemophilus influenzae type B disease in five young children\u2014Minnesota, 2008","volume":"58","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"key\n\t\t\t\t20170522100643_KWS317C33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/biomet\/64.2.191","article-title":"Group sequential methods in the design and analysis of clinical trials","volume":"64","author":"Pocock","year":"1977","journal-title":"Biometrika"},{"issue":"1","key":"key\n\t\t\t\t20170522100643_KWS317C34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2307\/2531959","article-title":"Approximately optimal one-parameter boundaries for group sequential trials","volume":"43","author":"Wang","year":"1987","journal-title":"Biometrics"},{"issue":"3","key":"key\n\t\t\t\t20170522100643_KWS317C35","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.0006-341X.1999.00874.x","article-title":"A unifying family of group sequential test designs","volume":"55","author":"Kittleson","year":"1999","journal-title":"Biometrics"},{"key":"key\n\t\t\t\t20170522100643_KWS317C36","first-page":"135","volume-title":"The Design and Analysis of Sequential Clinical Trials","author":"Whitehead","year":"2000","edition":"Revised 2nd ed"},{"key":"key\n\t\t\t\t20170522100643_KWS317C37","article-title":"Methods for observational post-licensure medical product safety surveillance [published online ahead of print December 2, 2011]","author":"Nelson","journal-title":"Stat Methods Med Res"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170522100643_KWS317C38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/pds.2324","article-title":"Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data","volume":"21","author":"Nelson","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522100643_KWS317C39","article-title":"Sequential statistical methods for prospective post-marketing safety surveillance","volume-title":"Pharmacoepidemiology","author":"Kulldorff","year":"2011","edition":"5th ed"},{"issue":"12","key":"key\n\t\t\t\t20170522100643_KWS317C40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/pds.1509","article-title":"Early detection of adverse drug events within population-based health networks: application of sequential testing methods","volume":"16","author":"Brown","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"key\n\t\t\t\t20170522100643_KWS317C41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"key\n\t\t\t\t20170522100643_KWS317C42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4310\/SII.2012.v5.n4.a1","article-title":"Statistical performance of group sequential methods for observational post-licensure medical product safety surveillance: a simulation study","volume":"5","author":"Zhao","year":"2012","journal-title":"Stat Interface"},{"issue":"6","key":"key\n\t\t\t\t20170522100643_KWS317C43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/pds.2133","article-title":"Near real-time vaccine safety surveillance with partially accrued data","volume":"20","author":"Greene","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key\n\t\t\t\t20170522100643_KWS317C44","volume-title":"Report From the WHO Collaborating Centre for International Drug Monitoring: Activities July 2008\u2013June 2009","author":"WHO Collaborating Centre for International Drug Monitoring","year":"2009"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/177\/2\/131\/17340237\/kws317.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T20:09:22Z","timestamp":1562530162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/10.1093\/aje\/kws317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,4]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,1,4]]},"published-print":{"date-parts":[[2013,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kws317","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,4]]}}}